Chemical messengers synthesized and released by neurons that transmit signals across synaptic clefts to postsynaptic neurons, muscle cells, or glands. Major classes include amino acids (glutamate, GABA), monoamines (dopamine, serotonin, norepinephrine), acetylcholine, and neuropeptides, each with specific synthesis pathways, receptor families, and functional roles in neural communication, behavior, and systemic regulation.
Think of neurotransmitters as a city's postal system with different delivery services. Glutamate is the express courier—fast, direct, opens ion channel "mailboxes" immediately (milliseconds). GABA is the "return to sender" service that stops messages from spreading. Dopamine and serotonin are like priority mail with tracking—they don't deliver packages directly, but instead leave instructions (via G-protein receptors) that change how the building (neuron) operates for hours. Each neurotransmitter is made in a specific factory (synthesis pathway) from raw materials (dietary precursors like tryptophan or tyrosine), packaged into delivery trucks (vesicles), and released when calcium "unlocks the loading dock" during an action potential. After delivery, they're either recycled by reuptake pumps (like a postal service collecting empty boxes) or broken down by enzymes (shredded). Now here's the cPNI twist: inflammation is like a citywide strike. Cytokines IL-1β, IL-6, and TNF-α shut down neurotransmitter factories, jam the recycling pumps (increasing reuptake), and even change the locks on mailboxes (alter receptor sensitivity). This is why inflamed patients experience depression, fatigue, and cognitive fog—the postal system collapses even though the buildings (neurons) are structurally intact.
Synthesis pathways:
- Dopamine/norepinephrine: Tyrosine → (tyrosine hydroxylase + BH4) → L-DOPA → (aromatic amino acid decarboxylase + B6) → dopamine → (dopamine β-hydroxylase + vitamin C) → norepinephrine
- Serotonin: Tryptophan → (tryptophan hydroxylase + BH4) → 5-HTP → (aromatic amino acid decarboxylase + B6) → serotonin (5-HT)
- GABA: Glutamate → (glutamic acid decarboxylase + B6) → GABA
- Acetylcholine: Choline + acetyl-CoA → (choline acetyltransferase) → acetylcholine
Synaptic transmission cascade:
- Action potential depolarizes presynaptic terminal
- Voltage-gated Ca²⁺ channels open → intracellular Ca²⁺ rises from ~100 nM to >10 μM
- Ca²⁺ binds synaptotagmin on vesicles → SNARE complex assembly (synaptobrevin, syntaxin, SNAP-25)
- Vesicle fusion → neurotransmitter release into synaptic cleft (20-40 nm gap)
- Neurotransmitter diffusion across cleft (~0.5 ms)
- Receptor binding:
- Ionotropic (NMDA, AMPA, GABAA, nicotinic): ligand-gated ion channels → immediate depolarization/hyperpolarization (1-5 ms response)
- Metabotropic (D1-5, 5-HT1-7, α/β-adrenergic, mAChR): G-protein coupled → second messengers (cAMP, IP3, DAG) → kinase cascades (PKA, PKC) → transcription factor activation (CREB) → gene expression changes (minutes to hours)
Termination mechanisms:
- Reuptake: Transporters (SERT, DAT, NET) use Na⁺ gradient to pump neurotransmitter back into presynaptic neuron
- Enzymatic degradation: MAO (monoamine oxidase), COMT (catechol-O-methyltransferase), acetylcholinesterase
- Diffusion: Spillover to extrasynaptic receptors or glial uptake
Inflammatory disruption mechanisms:
graph TD
A["Inflammatory Cytokines<br/>IL-1β, IL-6, TNF-α, IFN-γ"] --> B[IDO Activation]
A --> C[p38 MAPK Activation]
A --> D[Microglial Activation]
B --> E["Tryptophan → Kynurenine"]
E --> F["↓ Serotonin Synthesis"]
E --> G["↑ Quinolinic Acid<br/>NMDA agonist"]
C --> H["↑ Reuptake Transporter Expression<br/>SERT, DAT, NET"]
C --> I[BH4 Oxidation]
I --> J["↓ Tyrosine Hydroxylase Activity"]
J --> K["↓ Dopamine Synthesis"]
D --> L["↑ Glutamate Release"]
D --> M["↓ Glutamate Reuptake<br/>via astrocyte GLT-1"]
L --> N[Excitotoxicity]
M --> N
A --> O["↓ BDNF Expression"]
O --> P["↓ Synaptic Plasticity"]
H --> Q["↓ Synaptic Availability"]
Q --> R["Depression, Anhedonia<br/>Cognitive Dysfunction"]
F --> R
K --> R
N --> R
P --> R
Specific inflammatory effects:
- IL-1β activates p38 MAPK → phosphorylates SERT → increases serotonin reuptake by 40-60%
- IFN-γ induces IDO → tryptophan catabolism increases 3-5× → serotonin precursor availability drops
- TNF-α oxidizes tetrahydrobiopterin (BH4) → uncouples tyrosine hydroxylase → produces superoxide instead of L-DOPA
- IL-6 >10 pg/mL correlates with 30% reduction in striatal dopamine release (measured via PET)
Neurotransmitter dysfunction is the primary mechanism linking systemic inflammation to mood disorders, fatigue, and cognitive symptoms in cPNI. This represents a fundamental shift from the traditional "chemical imbalance" model—the imbalance is not primary but rather a consequence of immune activation.
Key clinical patterns:
Depression subtypes by neurotransmitter profile:
-
Inflammatory depression: High CRP (>3 mg/L), elevated IL-6, kynurenine/tryptophan ratio >0.05 → reduced serotonin synthesis, dopamine depletion, glutamate excess. Characterized by anhedonia, psychomotor retardation, fatigue. Poor SSRI response (STAR*D trial: 50% fail first antidepressant). Responds to anti-inflammatory approaches (omega-3 EPA >2g/day, curcumin 1g/day, lifestyle interventions).
-
Dopaminergic depression: Basal ganglia inflammation → impaired motivation, effort-based decision-making, reward processing. Nucleus accumbens dopamine release reduced by 20-35% in inflammatory states. Clinically presents as severe anhedonia, psychomotor slowing, fatigue disproportionate to mood. Benefits from dopamine precursors (L-tyrosine 1-2g/day), anti-inflammatory protocols, exercise (increases striatal dopamine synthesis).
Cognitive dysfunction in chronic inflammation:
- Prefrontal glutamate/GABA imbalance → executive dysfunction, working memory deficits
- Hippocampal neuroinflammation → impaired BDNF signaling → reduced neurogenesis and long-term potentiation
- Observable in long COVID, chronic fatigue syndrome, autoimmune diseases
Metamodel connections:
- Metamodel 5+2 (Immune Intelligence): Selfish immune system hijacks neurotransmitter metabolism to enforce sickness behavior—reduced dopamine suppresses foraging/social activity, increased kynurenine pathway metabolites promote rest
- Evolutionary mismatch: Chronic low-grade inflammation (metaflammation) from modern diet/sedentarism creates persistent neurotransmitter disruption where acute inflammatory neurotransmitter suppression was adaptive (rest during infection)
Intervention strategy:
- Address inflammation first: Anti-inflammatory diet, omega-3s, exercise, stress reduction—targeting root cause
- Support synthesis: Cofactors (B6 50-100mg, folate 400-800μg, B12 500-1000μg, vitamin C 1-2g, iron if deficient, zinc 15-30mg, magnesium 300-400mg)
- Precursor loading: Tryptophan 1-2g or 5-HTP 50-200mg (serotonin), tyrosine 1-2g (dopamine), only after inflammation controlled
- Microbiome support: SCFAs modulate neurotransmitter synthesis and BBB permeability
Clinical thresholds:
- Kynurenine/tryptophan ratio >0.052 predicts inflammatory depression with 80% sensitivity
- IL-6 >3.5 pg/mL associated with treatment-resistant depression
- CRP >3 mg/L predicts poor antidepressant response
- Four main neurotransmitter classes: amino acids (glutamate, GABA), monoamines (dopamine, serotonin, norepinephrine), acetylcholine, neuropeptides
- Ionotropic receptors mediate fast synaptic transmission (1-5 ms), metabotropic receptors modulate over minutes-hours via G-protein signaling
- Serotonin synthesis requires tryptophan (dietary essential), BH4 cofactor, vitamins B6 and folate—any deficiency impairs production
- Dopamine synthesis requires tyrosine, BH4, vitamin C, B6, iron (for tyrosine hydroxylase)—inflammation oxidizes BH4, uncoupling synthesis
- IDO activation during inflammation diverts >70% of tryptophan to kynurenine pathway instead of serotonin synthesis
- IL-1β increases serotonin reuptake transporter (SERT) expression by 40-60% within 4 hours via p38 MAPK
- Inflammatory cytokines reduce BDNF expression by 30-50%, impairing synaptic plasticity and neurogenesis
- 95% of body's serotonin is in the gut (enterochromaffin cells), but cannot cross blood-brain barrier—brain synthesis is independent
- Gut microbiome produces GABA (Lactobacillus, Bifidobacterium), influences dopamine via tyrosine production, modulates tryptophan availability
- Chronic stress + inflammation creates "double hit": cortisol impairs GR signaling → persistent cytokine production → sustained neurotransmitter disruption
- Glutamate excitotoxicity during neuroinflammation: microglia release glutamate while reducing astrocyte GLT-1 reuptake → NMDA receptor overactivation
- COMT Val158Met polymorphism: Met/Met genotype has 3-4× slower dopamine degradation in PFC—more vulnerable to inflammatory dopamine depletion
- Exercise acutely increases dopamine synthesis in striatum by 50-100%, reduces inflammatory cytokines—dual mechanism antidepressant effect
- neurons — presynaptic neurons synthesize and release neurotransmitters; postsynaptic neurons express receptors that respond to neurotransmitter binding
- synaptic plasticity — neurotransmitter-mediated changes in receptor density, dendritic spine morphology, and synaptic strength underlie learning and memory
- Cytokines — inflammatory cytokines (IL-1β, IL-6, TNF-α, IFN-γ) directly impair neurotransmitter synthesis, increase reuptake, and alter receptor sensitivity
- inflammation — systemic and neuroinflammation disrupt neurotransmitter metabolism via multiple mechanisms including IDO activation and BH4 oxidation
- Dopamine — major catecholamine neurotransmitter, synthesis blocked by inflammatory BH4 depletion, critical for motivation and reward processing
- Serotonin — monoamine derived from tryptophan, synthesis impaired when inflammation diverts tryptophan to kynurenine pathway via IDO
- glutamate — primary excitatory neurotransmitter, excess release by activated microglia combined with reduced astrocyte reuptake causes excitotoxicity
- GABA — primary inhibitory neurotransmitter synthesized from glutamate via GAD enzyme requiring B6 cofactor
- norepinephrine — catecholamine synthesized from dopamine, modulates arousal, attention, and stress responses via α- and β-adrenergic receptors
- Acetylcholine — synthesized from choline and acetyl-CoA, mediates neuromuscular transmission and parasympathetic signaling
- Neuropeptides — larger peptide neurotransmitters (substance P, neuropeptide Y, oxytocin) with slower, modulatory effects
- Depression — inflammatory depression characterized by reduced serotonin/dopamine synthesis, increased reuptake, altered receptor function—mechanistically distinct from non-inflammatory depression
- kynurenine pathway — inflammatory activation shunts tryptophan away from serotonin synthesis toward kynurenine and neurotoxic quinolinic acid
- indoleamine 2,3-dioxygenase — IDO enzyme activated by IFN-γ and other cytokines, catabolizes tryptophan, reducing serotonin precursor availability by 70%+
- BDNF — brain-derived neurotrophic factor essential for synaptic plasticity and neurogenesis, expression reduced 30-50% by inflammatory cytokines
- gut microbiome — produces neurotransmitter precursors (tyrosine from protein fermentation), synthesizes GABA directly, modulates tryptophan metabolism
- basal ganglia — striatal dopamine circuits particularly vulnerable to inflammatory disruption, resulting in anhedonia and psychomotor slowing
- ventromedial prefrontal cortex — prefrontal neurotransmitter function (dopamine, serotonin) impaired by inflammation, affecting emotional regulation and decision-making
- nucleus accumbens — reward center where inflammatory cytokines reduce dopamine release by 20-35%, causing anhedonia and reduced motivation
- neuroinflammation — microglial activation in brain parenchyma directly releases cytokines that disrupt local neurotransmitter metabolism
- Anxiety — altered GABA/glutamate balance and noradrenergic hyperactivity contribute to anxiety symptoms in inflammatory states
- fatigue — dopamine depletion in motor circuits and orexin system dysfunction from inflammatory neurotransmitter disruption cause severe fatigue
- cognitive dysfunction — prefrontal glutamate excess, reduced acetylcholine, impaired dopamine signaling cause executive dysfunction and memory deficits
- B vitamins — B6 required for aromatic amino acid decarboxylase (serotonin, dopamine synthesis) and GAD (GABA synthesis); folate/B12 for methylation and BH4 regeneration
- Magnesium — cofactor for tyrosine hydroxylase and NMDA receptor regulator, deficiency impairs dopamine synthesis and increases glutamate excitotoxicity
- Zinc — cofactor for multiple neurotransmitter synthesis enzymes, modulates NMDA receptors, deficiency associated with depression and cognitive impairment
- iron — required for tyrosine hydroxylase (rate-limiting enzyme in dopamine/norepinephrine synthesis), deficiency causes dopaminergic dysfunction
- Tryptophan — essential amino acid precursor for serotonin, availability reduced by IDO-mediated catabolism during inflammation
- muscle — skeletal muscle releases myokines during contraction that reduce systemic inflammation and increase BDNF, supporting neurotransmitter function
- Calcium — triggers vesicle fusion and neurotransmitter release, intracellular concentration rises from 100 nM to >10 μM during action potential
- stress — chronic stress activates HPA axis and inflammatory pathways, creating sustained neurotransmitter disruption
- reward — dopaminergic reward circuitry in ventral striatum/nucleus accumbens is primary target of inflammatory neurotransmitter disruption
- Module 1 — Introduction to neurons, neurotransmitters, and basic neural signaling
- Module 3 — Neuroimmune interactions, inflammatory effects on neurotransmission, clinical applications